Especially ones measuring apples and oranges ...LOL...you have triewd for years to tell us how MAKO is the next ISRG and now you are trying tell us that its apples and oranges???Point being that you were comparing academic adoption of ISRG now with MAKO academic adoption now. If you don't compare at the same point in the TALC, it is a meaningless comparison. Indeed, any point in time is likely to be meaningless without the curve to look at.There is no comparison with academic adoption for ISRG vs MAKO as well. Look it up yourself. By practically any measure.....ISRG has been adopted faster. Go ahead and find the data yourself since you question it.As to comparing to the same point on the TALC????? Me thinks you just want to argue for argue sake. The TALC IS the issue.......adoption........you CANNOT look at the same point on the curve without making the mistaken assumption that both technologies will be adopted to begin with. As for your "by any measure", there are many kinds of comparison that one can make and it is very clear that you aren't making themOK so again.....what measure would you like to look at??? Show me where adoption of MAKO has been greater, faster, profitable, etc. as compared to ISRG over time.To me, any comparison that doesn't look at the overall curve is going to be a crapshoot as to what it might say, especially if one compares different points in each company's TALC for each product ... hips being brand new for MAKO, for example.You do not seem to understand that ISRG has grown by numerous TALC's......prostate, then GYN, then whatever is next. MAKO has gotten stuck at the chasm with its unicompartment strategy.ISRG had hit the screws (and continues to do so) years before MAKO over the same timeframe.......by practically any measure.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat